To use the pen, you dial the prescribed dose, press the needle into the skin, and press the button to administer the medication
Eligibility and dosing The tablet is licensed for adults with obesity, with a body mass index (BMI) of 30 or above, or those who are overweight with a BMI between 27 and 30 with at least one weight-related comorbidity, alongside a reduced-calorie diet and increased physical activity
doi:10.7326/M20-0864 15
Ozempic (Injection) Indication : Type 2 Diabetes, cardiovascular risk reduction Frequency : Weekly Wegovy (Injection) Indication : Chronic weight management (obesity or overweight with comorbidities) Frequency : Weekly Rybelsus (Tablet) Indication : Type 2 Diabetes
While higher doses deliver the most significant weight loss and metabolic benefits, they also increase the risk and severity of gastrointestinal (GI) issues
Working with a clinician (such as a clinician at Midi Health) is key, so you can talk about your specific needs, health goals, and other health concerns
